サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1387290

症候性マルチプレックス診断市場レポート：2030年までの動向、予測、競合分析

Syndromic Multiplex Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

症候性マルチプレックス診断市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月31日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

症候性マルチプレックス診断の動向と予測

世界の症候性マルチプレックス診断市場は、2024年から2030年までのCAGRが7.5%で、2030年までに推定42億5,000万米ドルに達すると予測されます。この市場の主な促進要因は、感染症の蔓延の増加、分子診断技術の採用の増加、正確で迅速な結果と治療への迅速なアクセスに対する需要の高まりです。世界の症候性マルチプレックス診断市場の将来は、病院と診断研究所市場でのビジネスチャンスにより有望視されています。

症候性マルチプレックス診断市場洞察

Lucintelの予測では、胃腸炎や食中毒のような疾病の原因となる病原体の特定に役立つことから、予測期間中、消化器系がより大きなセグメントであり続けると予想されます。

この市場の中では、病院での診断検査が多いことから、病院が最大のセグメントであり続けると予想されます。

北米は、ヘルスケア支出の増加、早期かつ正確な診断に対する需要の高まり、様々な伝染性疾患や非伝染性疾患の有病率の増加により、予測期間中最大の地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どの分野がより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の症候性マルチプレックス診断市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の症候性マルチプレックス診断市場動向（2018-2023）と予測（2024-2030）
  • タイプ別の世界の症候性マルチプレックス診断市場
    • 呼吸器系
    • 消化器系
    • 中枢神経系
    • その他
  • 最終用途別の世界の症候性マルチプレックス診断市場
    • 病院
    • 診断研究所
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の症候性マルチプレックス診断市場
  • 北米の症候性マルチプレックス診断市場
  • 欧州の症候性マルチプレックス診断市場
  • アジア太平洋の症候性マルチプレックス診断市場
  • その他地域の症候性マルチプレックス診断市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • タイプ別の世界の症候性マルチプレックス診断市場の成長機会
    • 最終用途別の世界の症候性マルチプレックス診断市場の成長機会
    • 地域別の世界の症候性マルチプレックス診断市場の成長機会
  • 世界の症候性マルチプレックス診断市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の症候性マルチプレックス診断市場の能力拡大
    • 世界の症候性マルチプレックス診断市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • BioMerieux
  • Qiagen
  • DiaSorin S.p.A
  • Applied BioCode
  • Akonni Biosystems
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Accelerate Diagnostic
  • Becton and Dickinson
  • Hologic
目次

Syndromic Multiplex Diagnostic Trends and Forecast

The future of the global syndromic multiplex diagnostic market looks promising with opportunities in the hospitals and diagnostics laboratories markets. The global syndromic multiplex diagnostic market is expected to reach an estimated $4.25 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious disease, rising adoption of molecular diagnostic techniques, and growing demand for accurate and rapid results and quick access to the treatment.

A more than 150-page report is developed to help in your business decisions.

Syndromic Multiplex Diagnostic by Segment

The study includes a forecast for the global syndromic multiplex diagnostic by type, end use, and region.

Syndromic Multiplex Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Respiratory
  • Gastrointestinal
  • Central Nervous System
  • Others

Syndromic Multiplex Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostics Laboratories
  • Others

Syndromic Multiplex Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Syndromic Multiplex Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies syndromic multiplex diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the syndromic multiplex diagnostic companies profiled in this report include-

  • Biomerieux
  • Qiagen
  • Diasorin S.P.A
  • Applied Biocode
  • Akonni Biosystems
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Accelerate Diagnostic
  • Becton and Dickinson
  • Hologic

Syndromic Multiplex Diagnostic Market Insights

Lucintel forecasts that gastrointestinal will remain the larger segment over the forecast period as it helps in identifing pathogens responsible for diseases like gastroenteritis and foodborne illnesses.

Within this market, hospitals is expected to remain the largest segment due to the high volume of diagnostic tests performed in hospitals.

North America will remain the largest region during the forecast period due to rising healthcare expenditure, growing demand for early and accurate diagnosis, and increasing prevalence of various communicable or non-communicable diseases.

Features of the Global Syndromic Multiplex Diagnostic Market

Market Size Estimates: Syndromic multiplex diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Syndromic multiplex diagnostic market size by type, end use, and region in terms of value ($B).

Regional Analysis: Syndromic multiplex diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the syndromic multiplex diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the syndromic multiplex diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the syndromic multiplex diagnostic market size?

Answer: The global syndromic multiplex diagnostic market is expected to reach an estimated $4.25 billion by 2030.

Q2. What is the growth forecast for syndromic multiplex diagnostic market?

Answer: The global syndromic multiplex diagnostic market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the syndromic multiplex diagnostic market?

Answer: The major drivers for this market are increasing prevalence of infectious disease, rising adoption of molecular diagnostic techniques, and growing demand for accurate and rapid results and quick access to the treatment.

Q4. What are the major segments for syndromic multiplex diagnostic market?

Answer: The future of the syndromic multiplex diagnostic market looks promising with opportunities in the hospitals and diagnostics laboratories markets.

Q5. Who are the key syndromic multiplex diagnostic market companies?

Answer: Some of the key syndromic multiplex diagnostic companies are as follows:

  • Biomerieux
  • Qiagen
  • Diasorin S.P.A
  • Applied Biocode
  • Akonni Biosystems
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Accelerate Diagnostic
  • Becton and Dickinson
  • Hologic

Q6. Which syndromic multiplex diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that gastrointestinal will remain the larger segment over the forecast period as it helps in identifing pathogens responsible for diseases like gastroenteritis and foodborne illnesses.

Q7. In syndromic multiplex diagnostic market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region during the forecast period due to rising healthcare expenditure, growing demand for early and accurate diagnosis, and increasing prevalence of various communicable or non-communicable diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the syndromic multiplex diagnostic market by type (respiratory, gastrointestinal, central nervous system, and others), end use (hospitals, diagnostics laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Syndromic Multiplex Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Syndromic Multiplex Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Syndromic Multiplex Diagnostic Market by Type
    • 3.3.1: Respiratory
    • 3.3.2: Gastrointestinal
    • 3.3.3: Central Nervous System
    • 3.3.4: Others
  • 3.4: Global Syndromic Multiplex Diagnostic Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Diagnostics Laboratories
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Syndromic Multiplex Diagnostic Market by Region
  • 4.2: North American Syndromic Multiplex Diagnostic Market
    • 4.2.2: North American Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
  • 4.3: European Syndromic Multiplex Diagnostic Market
    • 4.3.1: European Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
    • 4.3.2: European Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
  • 4.4: APAC Syndromic Multiplex Diagnostic Market
    • 4.4.1: APAC Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
    • 4.4.2: APAC Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
  • 4.5: ROW Syndromic Multiplex Diagnostic Market
    • 4.5.1: ROW Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
    • 4.5.2: ROW Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by Type
    • 6.1.2: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by End Use
    • 6.1.3: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Syndromic Multiplex Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Syndromic Multiplex Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Syndromic Multiplex Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: BioMerieux
  • 7.2: Qiagen
  • 7.3: DiaSorin S.p.A
  • 7.4: Applied BioCode
  • 7.5: Akonni Biosystems
  • 7.6: Thermo Fisher Scientific
  • 7.7: Abbott Laboratories
  • 7.8: Accelerate Diagnostic
  • 7.9: Becton and Dickinson
  • 7.10: Hologic